Daily as of 2 Sep 16:00 ET
- Price
- above both $135.07 vs 50 $134.13 / 200 $91.97
- Projection
- No cross projected
- Test
- No active test
- Last cross
- ๐จGolden cross 14 Oct 2025 ยท projected 17 bars out
Apogee Therapeutics (APGE) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.
APGE stopped trading under this ticker on 2 Sep 2026.
No weekly data
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 14 Oct 2025 | ๐จGolden moderate | daily | 17 bars out | Not tested |
| 27 Dec 2024 | ๐Death | daily | 6 bars out | 2 bar cross test |
Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.